Loading...

Majority of Americans Have Struggled with Mental Health

According to a recent (11/23) study by Statista of 2074 adults, one in two of Americans experienced stress and/or anxiety in the preceding twelve months. Note that only 22% of respondents have indicated that they have not recently experienced any...

Cervella CES now available in Chile.

El dispositivo médico es un tratamiento no farmacológico, portátil y sin efectos secundarios para tratar la ansiedad, insomnio y depresión. Con una duración de 30 minutos al día, el 92% de los pacientes registró una tasa de mejoría en sus afecciones luego de tan solo 60 días de aplicación.

Update to Android Cervella App (V3.1)

  Effective 1/30/2023, Google implemented new policy which necessitated an update to the Cervella App for Android devices. Customers for who the Cervella app is working do not need to update or do anything.   The new Cervella App (V3.1)...

Interview with our President and CEO at Into Tomorrow

Free device authorization for Cervella now available

We now offer a medical device authorization screening through an independent licensed healthcare provider at no extra cost to you!

Article about Cervella in Indianapolis Medical Society Newsletter

Check out the article about the history of CES and the origins of Cervella in the February issue of Indianapolis Medical Society’s Newsletter.

Why Antidepressants Stop Working

Recently, there was an interesting article published in the Wall Street Journal entitled, “Why Your Antidepressants Seem to Stop Working—and What to Do.” The article describes a surprisingly frequent scenario of antidepressant drugs losing their effectiveness with time or simply...

Surgeon General’s Report on Youth Mental Health Crisis

Surgeon's General Report illustrates the devastating effect of the pandemic on the adolescents and young adults.

Article comparing medical devices for Anxiety, Insomnia, and Depression

Interesting article showcasing various approaches to treatment of Anxiety, Insomnia, and Depression. It is important to underscore that currently only Cranial Electrical Stimulation is FDA-cleared as the technology for treatment of the disorders.

Cervella Anxiety Insomnia, and Depression Long-Term Patient Study Results

Cervella presents results of year-long study on treatment of Anxiety and Insomnia.

New Cervella Apple iOS App Update

We have released a new major version of the Cervella Cervella app (version 3.0) available on the Apple App Store.

Cervella receives US Patent

We are very pleased to have received the US Patent # 10,857,360 for our Cervella Cranial Electrotherapy Stimulator.

Cervella Android App V3.0

We have released a new version of the Android Cervella app (version 3.0) available on the Google Play Store.

Cervella Charging Questions

We occasionally receive questions regarding Cervella charging. Below, we would like to offer you some explanations: First, please understand that there are two, independent, batteries that you have to charge. First battery is inside the Cervella stimulator (the square device...

Cervella Ear Cushions | User FAQs

Under normal use and with care, the ear cushions should last for 6-12 months. If your device is working intermittently (as indicated by the BLUE LED going from blinking to solid and the app timer pausing) you may be due...

Did You Know?

Did You Know … You can easily test the Cervella system for proper set-up and operation by connecting the Cervella to the headset with the cable, starting the treatment in the Cervella App, and gently touching the Cervella electrodes (the...

How a Tiny Electrical Current to the Brain Is Treating Medical Symptoms

The Cervella device was mentioned in the recent issue of IEEE Pulse which is a magazine discussing advances in medical devices and biology in society.

Frequently Asked Questions

Now that most of the pre-orders are in the hands of patients and clinicians, we complied a list of some of the frequently asked questions. We would also like to provide you with some tips in order to make your...

Cervella for Quarantined Patients

The COVID-19 pandemic has significantly increased the number of patients needing to stay in isolation/quarantine for an extended period of time. Many of the quarantined patients have or are beginning to show symptoms of anxiety and often comorbid depression or...

Our Story in the Indianapolis Business Journal

Today, we have received a great coverage by the Indianapolis Business Journal.